NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.

about

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.

Item

http://www.wikidata.org/entity/Q48100633

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

NRG oncology RTOG 9006: a phas ...... for malignant glioma patients.

@en

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy

@nl

type

Item

label

NRG oncology RTOG 9006: a phas ...... for malignant glioma patients.

@en

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy

@nl

prefLabel

NRG oncology RTOG 9006: a phas ...... for malignant glioma patients.

@en

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy

@nl

P1476

NRG oncology RTOG 9006: a phas ...... for malignant glioma patients.

@en

P2093

A Jennifer Fischbach

http://www.w3.org/2001/XMLSchema#string

Alan C Hartford

http://www.w3.org/2001/XMLSchema#string

Arnold M Markoe

http://www.w3.org/2001/XMLSchema#string

Benjamin Movsas

http://www.w3.org/2001/XMLSchema#string

Christopher J Schultz

http://www.w3.org/2001/XMLSchema#string

Christopher U Jones

http://www.w3.org/2001/XMLSchema#string

Harold E Kim

http://www.w3.org/2001/XMLSchema#string

Jeff M Michalski

http://www.w3.org/2001/XMLSchema#string

Kwang N Choi

http://www.w3.org/2001/XMLSchema#string

Madhur K Garg

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.

Prognostic value of H-MLH1 after adjusting for RPA class in GBM patients.

Radiation response of the central nervous system.

P2888

s11060-017-2558-x

P304

39-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2558-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Arif N Ali

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29404979

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

phase III clinical trial

P932

6020014

http://www.w3.org/2001/XMLSchema#string